Premium
Long‐term outcome in Serbian patients with Wilson disease
Author(s) -
Svetel M.,
Pekmezović T.,
Petrović I.,
Tomić A.,
Kresojević N.,
Ješić R.,
Kažić S.,
Raičević R.,
Stefanović D.,
Delibašić N.,
Živanović D.,
?or?ević M.,
Kostić V. S.
Publication year - 2009
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/j.1468-1331.2009.02607.x
Subject(s) - medicine , disease , wilson's disease , cohort , pediatrics , surgery
Background and purpose: To investigate survival rates, prognostic factors, and causes of death in Wilson disease (WD). Methods: In the years 1980–2007, a cohort of 142 patients with WD was prospectively registered (54 presented with neurologic symptoms, 49 with hepatic symptoms, 33 had mixed form, and data were missing for six patients). The duration of follow‐up for patients alive was 11.1 ± 8.8 years. Results: After initiation of treatment (d‐penicillamine and zinc salts), 79% of patients had a stable or improved course of disease. Despite early diagnosis and appropriate therapy, 15 patients still had a relentlessly progressive course. Thirty patients died. The cumulative probability of survival in a 15‐year period for the whole group was 76.7 ± 4.9%. Better prognosis of WD was associated with male sex, younger age at onset, neurologic form of the disease, and treatment continuity. Causes of death were predominantly related to hepatic failure (16 patients), but also suicide (four patients) and cancer (three patients). Conclusion: Despite the relatively early diagnosis and treatment of our patients with WD, mortality was still considerably high.